logo
Select company
Select metric
$ 10.55MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
40
Sector
77
Industry
91
History
83
$ 1.86Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.37M$ 9.18M$ 10.55M
3/31/2025$ 1.33M$ 5.83M$ 7.16M
12/31/2024$ 1.3M$ 5.22M$ 6.52M
9/30/2024$ 1.28M$ -9.04M$ -7.76M
6/30/2024$ 1.26M$ -14.45M$ -13.19M
3/31/2024$ 1.23M$ 8.41M$ 9.64M
12/31/2023$ 1.19M$ 10.46M$ 11.65M
9/30/2023$ 1.15M$ 14.74M$ 15.89M
6/30/2023$ 1.12M$ 12.87M$ 13.99M
3/31/2023$ 1.1M$ -12.79M$ -11.69M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ 3.49M.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average EBITDA has been $ -2.63M.
  • The median EBITDA for PROTALIX BIOTHERAPEUTICS INC during this period was $ -6.09M
  • PROTALIX BIOTHERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 15.89M.
  • The lowest EBITDA recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe $ -19.34M

PROTALIX BIOTHERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CSBR : CHAMPIONS ONCOLOGY INC $ 4.42MTHTX : THERATECHNOLOGIES INC $ 7.31MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 14.78MSPRO : SPERO THERAPEUTICS INC $ -53.6MENTA : ENANTA PHARMACEUTICALS INC $ -82.41MCELU : CELULARITY INC $ -58.15MIVVD : INVIVYD INC $ -106.81MDOMH : DOMINARI HOLDINGS INC $ -18.5MSGMO : SANGAMO THERAPEUTICS INC $ -55.42MALEC : ALECTOR INC $ -105.9M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: EBIT [ $ 2.07M ] + DepAmor [ $ 1.42M ]
(=) EBITDA [ $ 3.49M ]

PLX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -19.34M

Minimum

Dec 31, 2021

$ 15.89M

Maximum

Sep 30, 2023

$ -2.63M

Average

$ -6.09M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M